GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gennex Laboratories Ltd (BOM:531739) » Definitions » Debt-to-Equity

Gennex Laboratories (BOM:531739) Debt-to-Equity : N/A (As of Dec. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Gennex Laboratories Debt-to-Equity?

Gennex Laboratories's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₹0 Mil. Gennex Laboratories's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₹0 Mil. Gennex Laboratories's Total Stockholders Equity for the quarter that ended in Dec. 2024 was ₹0 Mil.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Gennex Laboratories's Debt-to-Equity or its related term are showing as below:

BOM:531739' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.06   Med: 0.14   Max: 0.25
Current: 0.16

During the past 13 years, the highest Debt-to-Equity Ratio of Gennex Laboratories was 0.25. The lowest was 0.06. And the median was 0.14.

BOM:531739's Debt-to-Equity is ranked better than
63.4% of 817 companies
in the Drug Manufacturers industry
Industry Median: 0.27 vs BOM:531739: 0.16

Gennex Laboratories Debt-to-Equity Historical Data

The historical data trend for Gennex Laboratories's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gennex Laboratories Debt-to-Equity Chart

Gennex Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.14 0.19 0.23 0.22 0.11

Gennex Laboratories Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A 0.11 N/A 0.16 N/A

Competitive Comparison of Gennex Laboratories's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Gennex Laboratories's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gennex Laboratories's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gennex Laboratories's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Gennex Laboratories's Debt-to-Equity falls into.


;
;

Gennex Laboratories Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Gennex Laboratories's Debt to Equity Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Gennex Laboratories's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gennex Laboratories  (BOM:531739) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Gennex Laboratories Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Gennex Laboratories's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Gennex Laboratories Business Description

Traded in Other Exchanges
N/A
Address
Akash Ganga, Plot No. 144, 4th Floor, Srinagar Colony, Hyderabad, TG, IND, 500 073
Gennex Laboratories Ltd is engaged in the manufacturing of bulk drugs, and intermediates, Biotech Products. Geographically, the group has a business presence in Bangladesh, Egypt, Germany, Guatemala, Iran, Israel and other countries. Its products include Guaifenesin, Methocarbamol, Fluconazole and Phenazopyridine, among others.

Gennex Laboratories Headlines

No Headlines